Bausch Health Companies Inc.

Bausch Health Companies Inc.

Canadian multinational specialty pharmaceutical company

Key facts

Legal NameBausch Health Companies Inc.
Company Operating StatusActive
Full AddressBausch Health Companies Inc., 2150 St. Elzéar Blvd., West Laval, Quebec, H7L 4A8, Canada
Legal Entity IdentifierKOO0397YRO83WY5MGD97
Previous NameBIOVAIL Corp
Stock SymbolBHC
Wikidata IDQ1700871

Capital structure

$325m total debt

InstrumentCouponMaturityAmountSource
Third Amendment Revolving Credit Facility - Letter of Credit Sublimit · First Lien SecuredUSD 250msource ↗
Swingline Facility · First Lien SecuredABR + applicable rateUSD 75msource ↗

Covenant analysis

CovenantTermvs marketSource
Financial Covenant Standstill · Financial MaintenanceBreach of Section 6.15(a) (revolving covenant) does not constitute an Event of Default with respect to Term Loans unless and until Required Revolving Lenders have accelerated the Revolving Loans and terminated commitments; breach of Section 6.15(b) (Second Incremental covenant) does not constitute an Event of Default for the Revolving Facility or other Term Loans unless Required Second Incremental Term Lenders have acceleratedsource ↗
Incremental Facility Capacity - Ratio-Based Basket · IncurrenceUnlimited incremental capacity if (i) secured indebtedness: Secured Leverage Ratio ≤ 4.25:1.00 on Pro Forma Basis; (ii) unsecured indebtedness: Total Leverage Ratio ≤ 5.25:1.00 or Interest Coverage Ratio ≥ 2.00:1.00loose 4.25x vs basket median 4x (n=54)source ↗
Investment General Basket · InvestmentInvestments up to the greater of $495,500,000 and 50% of Consolidated Adjusted EBITDA (plus Shared RP Amount, plus reinvestment credit)loose 50% vs basket median 20% (n=122)source ↗
Indebtedness - General Unsecured Basket · IndebtednessIndebtedness up to the greater of $595,000,000 and 60% of Consolidated Adjusted EBITDAloose 60% vs basket median 20% (n=122)source ↗
Restricted Debt Payments - General Basket · Restricted PaymentAdditional Restricted Debt Payments up to the greater of $248,000,000 and 25% of Consolidated Adjusted EBITDA plus the Shared RP Amountmarket 25% vs basket median 20% (n=122)source ↗
Restricted Payments - General Basket · Restricted PaymentAdditional Restricted Payments up to the greater of $297,300,000 and 30% of Consolidated Adjusted EBITDA (minus any Shared RP Amount utilization)market 30% vs basket median 20% (n=122)source ↗
Restricted Payments - Ratio-Based Basket · Restricted PaymentUnlimited Restricted Payments so long as Total Leverage Ratio ≤ 4.00:1.00 on Pro Forma Basismarket 4x vs basket median 4x (n=54)source ↗
Investment Ratio-Based Basket · InvestmentUnlimited Investments so long as Total Leverage Ratio ≤ 4.50:1.00 on Pro Forma Basisloose 4.5x vs basket median 4x (n=54)source ↗